Biotrin is a diagnostics company that specialises in providing a range of novel and proprietary tests for the clinician and research scientist. Established in 1992, the company has two distinct business units: Infectious Diseases, which provides tests for the detection of new and emerging viruses; and Biomarkers, which include a range of novel, proprietary biomarkers to assess organ and tissue damage.

Biotrin's headquarters are in Dublin, Ireland, where it conducts its R&D, manufacturing and marketing activities. The company sells directly in the US, through its subsidiary in France and also employs a network of over 40 distributors worldwide. The company currently employs 70 people and is EN46001 / ISO13485 certified. Biotrin is privately owned.